Log In
BCIQ
Print this Print this
 

NT-1654 (formerly TDI-165)

  Manage Alerts
Collapse Summary General Information
Company Neurotune AG
DescriptionBiologic targeted at stabilizing the neuromuscular junction
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/21/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today